Emic is an artificial intelligence platform designed to proactively guide user conversations and interactions. It operates by taking the lead in dialogue, moving beyond simple response generation to direct the flow of communication. This system aims to optimize conversational outcomes by actively steering the discussion toward defined objectives.
Funding
$145K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Pharmaceutical companies face challenges in accurately forecasting healthcare professional (HCP) behavior and optimizing commercial strategies for new therapies. Traditional market research methods are often time-consuming, leading to delayed insights and missed opportunities for market penetration and growth.
Solution
EmicAI provides an AI-powered platform that delivers rapid, data-driven market research to forecast oncologist prescribing behavior and inform commercial strategy development. The platform leverages AI-driven interviews with a network of oncologists to capture nuanced decision-making factors, enabling pharmaceutical companies to gain actionable insights within days. This accelerated research process allows for more confident therapy launches and effective post-launch optimization, maximizing market potential.
Target Audience
The primary customers are pharmaceutical and biotechnology companies seeking to optimize their commercial strategies and accelerate the market entry of new therapies.
Features
- AI-powered interview engine for qualitative data acquisition from healthcare professionals.
- Hybrid-AI analysis models for forecasting oncologist prescribing behavior with over 90% confidence.
- Rapid insights delivery, providing actionable market analysis in days rather than weeks or months.
- Comprehensive analysis across therapy lifecycle stages, including pre-clinical, pre-launch, and post-launch phases.
- Specific modules for disease landscaping, patient journey mapping, treatment landscape analysis, and competitor dynamic simulation.
- Tools for value proposition refinement, competitive positioning analysis, and adoption forecast modeling.
- Performance tracking capabilities for ATU monitoring and market share optimization.
- Access to a network of oncology Key Opinion Leaders for in-depth qualitative insights.